Veeva climbs after J.P. Morgan upgrades to 'overweight'

Veeva Systems

08/09/2025 15:48

Updates

**  Shares of healthcare tech firm Veeva Systems VEEV.N rise 2.2% to $279.04

** J.P. Morgan upgrades stock rating to "overweight" from "neutral"; raises PT to $330 from $290

** Brokerage says it is optimistic about new opportunities created by Veeva's partnership with IQVIA IQV.N (formerly IMS Health and Quintiles) and its use of Agentic Artificial Intelligence (AI)

** Last month, IQVIA and Veeva announced long-term partnerships covering both clinical and commercial areas, along with resolution of all outstanding disputes

** Veeva competes with Salesforce CRM.N and other software providers, but no one matches its product depth, especially across Vault CRM Suites, brokerage says

** Stock rated "buy" on average; median PT is $322 - data compiled by LSEG

** Including session move, stock up 32% YTD

 (Reporting by Akriti Shah and Kamal Choudhury in Bengaluru)

 ((akriti.shah@thomsonreuters.com))